Premium
The invisible scaffold…with invisible benefits?
Author(s) -
Krishnan Sandeep K.,
Dean Larry S.
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27148
Subject(s) - medicine , multicenter study , mandate , randomized controlled trial , surgery , political science , law
Key Points Authors suggest the use of an investigator‐owned and directed, prospective, non‐randomized, single‐arm multicenter registry at 23 Italian hospitals to follow 500 STEMI patients who receive BVS. Follow‐up of patients is out to 5 years to determine how a BVS which has been deployed according to the IFU performs in these ACS patients. There is no comparator arm. Mandate that patients included in this registry follow a strict BVS implantation protocol which is felt to mitigate the not insignificant stent thrombosis rates noted with BVS to date.